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The search for high-affinity aptamers for targets such as proteins,
small molecules, or cancer cells remains a formidable endeavor. Sys-
tematic Evolution of Ligands by EXponential Enrichment (SELEX)
offers an iterative process to discover these aptamers through evo-
lutionary selection of high-affinity candidates from a highly diverse
random pool. This randomness dictates an unknown population dis-
tribution of fitness parameters, encoded by the binding affinities, to-
ward SELEX targets. Adding to this uncertainty, repeating SELEX
under identical conditions may lead to variable outcomes. These
uncertainties pose a challenge when tuning selection pressures to
isolate high-affinity ligands. Here, we present a novel stochastic hy-
brid model that describes the evolutionary selection of aptamers in
order to explore the impact of these unknowns. To our surprise, we
find that even single copies of high-affinity ligands in a pool of bil-
lions can strongly influence population dynamics, yet their survival
is highly dependent on chance. We perform Monte Carlo simulations
to explore the impact of environmental parameters, such as the tar-
get concentration, on selection efficiency in SELEX and identify new
strategies to control these uncertainties to ultimately improve the
outcome and speed of this time- and resource-intensive process.
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Understanding and exploiting target-ligand binding arebedrocks of the biomedical sciences and support a host of
applications ranging from diagnostics, therapeutics, and drug
discovery to biosensing, imaging, and gene regulation. Anti-
bodies and rational design provide a constructive playground
to develop these applications, yet there generally remains a
paucity of strong and specific binders for the innumerable
viral, protein, and small molecule targets under investigation.
Aptamers offer an alternative to antibodies, yet in spite
of their growth [1–4], the discovery of high-affinity aptamers
remains a challenge, especially for small molecule targets [5, 6].
Systematic Evolution of Ligands by EXponential Enrichment
(SELEX) [7, 8] is the premier framework for aptamer de-
velopment and isolates high-affinity ligands from an initial
library similar to how advantageous traits are enriched in a
biological population through Darwinian selection. In a cyclic
process, ligands are incubated with the target, and those that
exhibit preferential binding are amplified and survive to the
next round. Target molecules are typically immobilized on a
substrate material to facilitate easy separation of target-bound
and unbound ligands. Through numerous rounds of selection,
an initial library can be reduced to a handful of high-affinity
aptamers. Nucleic acids comprise the vast majority of libraries
used in SELEX, where sequence regions are randomized to
generate tremendous structural diversity. While this diversity
underpins the evolutionary nature of SELEX, numerous works
suggest that initial library design is a significant contributor
to its overall success [9].
While conceptually simple, the practical application of SE-
LEX is plagued by uncertainty. Despite the impact of library
design, the initial affinity distribution for any library toward a
specific target remains a priori unknown. Target immobiliza-
tion further complicates the procedure, particularly for small
molecules. In comparison to large molecular weight targets
such as proteins [10], viruses [11], and whole cells [12, 13]; the
immobilization of small molecules eliminates ligand binding
sites and is thus impractical. Newer approaches instead bind
the library itself to a substrate material using non-covalent
equilibrium binding, but this introduces the opportunity for
competitive losses of high-affinity ligands that are initially
present in extremely low numbers. Wash steps and other
experimental procedures may lead to further random losses,
while non-specific selection of ligands can counter environmen-
tal pressures and stall selection. In short, these uncertainties
may quickly compound to apply tremendous risk toward the
guarantee of successful selection.
Mathematical modeling therefore has great potential to
help understand the uncertainties of aptamer selection and
devise strategies to optimize environmental parameters and
improve selection outcomes. Previous models have explored
SELEX for protein targets, considering parameters such as
target concentration [14–16], separation efficiency of target-
bound and unbound ligand [17], nonspecific binding of DNA
to target [18], and negative selection steps [19]. These studies
predict that, in spite of its experimental complexity, the evo-
lutionary nature of SELEX guarantees selection of the highest
affinity ligand from the initial library. However, these works
focus primarily on the use of deterministic equilibrium equa-
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tions [14], whereas the presence of ligands in low copy numbers
and the role of other experimental uncertainties suggest the
use of more fundamental stochastic models rather than de-
terministic approximations. Mathematically, the chemical
master equation provides a framework to test this hypothesis
and generalize the above-mentioned deterministic models to
include intrinsic stochasticity [20]. While this approach could
be applied toward a purely stochastic model for SELEX, the
result cannot currently be solved analytically or simulated by
conventional techniques such as the Gillespie algorithm [21],
due to the large number of molecules present. These limita-
tions are common for many stochastic multiscale problems in
biology, chemistry and physics; and the development of novel
analytic approximations or numerical techniques to address
this problem is an important ongoing research topic [22].
Using these ideas as our foundation, we introduce a new
hybrid model for aptamer selection that builds on the chemical
master equation to introduce stochastic uncertainty in SELEX
modeling. Here, ligands are separated into two categories of
high and low copy number. In the former case, the master
equation is simplified toward a deterministic equilibrium sys-
tem, whereas in the latter it can be approximately solved
analytically. Unlike previous efforts to incorporate stochastic-
ity into aptamer modeling [23, 24], our framework allows us
to simultaneously investigate the impact of low copy number
ligands and their competitive binding to target molecules and
immobilization substrates among the presence of high copy
number ligands. Most importantly, this approach can capture
total loss of individual ligands, which can strongly contribute
to protocol outcome. Such events have not previously been
investigated and cannot be captured by other approximations
of the master equation such as the Langevin approximation,
which rely on the presence of sufficiently high numbers of
molecules and thereby diminish the possibility of extinction
events [25].
Using this framework, we investigate unexplored sources
of uncertainty in SELEX, beginning with a systematic anal-
ysis of the role the initial library affinity distribution plays
in selection. We further challenge the assumption that this
distribution is continuous at its tails and evaluate the impact
of adding noise at these extremes. We find that introducing
as few as 20 additional ligands outside the bulk distribution
of 1015 molecules can strongly affect the outcome of selection.
In light of these results, we revisit the topic of optimizing
target concentration as discussed in previous works [14–16],
and show that the assumed initial KD distribution strongly
influences protocol optimizations. We also provide additional
insights regarding non-covalent ligand immobilization to sup-
port more recent efforts to develop robust protocols for small
molecule SELEX [26–28]. Integrating these ideas, we show
that simultaneously lowering the target concentration and the
substrate binding dissociation constant over the SELEX cycles
can lead to improved selection outcomes for a wide range of
initial conditions.
Computational Model of Selection Dynamics
The original SELEX protocol [7, 8] serves as the basis for our
model, with additional modifications to accommodate small
molecule targets as described in [26]. While this marks the
first model that specifically considers small molecule targets,
the main ideas and conclusions derived from this work remain
Fig. 1. A sample candidate library of ligands Ai is prepared by letting the ligands
bind to a substrate S. Then, the target is added, leading to competitive binding
between the different apatamers for substrate and target molecules T . The ligands
still bound to the substrate are then separated from those which are either bound to a
target, or have randomly unbound from the substrate. The latter two are subsequently
amplified and taken into the next cycle.
applicable for other targets and selection schemes. The main
steps of our approach are summarized in Fig. 1. We begin
with a library of A˜toti ligands of type i, where i = {1, . . . ,MA}
andMA is the total number of unique ligands. The ligands are
then non-covalently immobilized using S˜ substrate molecules,
where KS is the ligand-substrate dissociation constant. These
complexes are then subjected to wash steps to remove unbound
ligands, from which A˜Ii ligands of type i survive. Surviving
ligands are then incubated with T˜ target molecules, where a
ligand of type i binds to the target with a dissociation constant
KD,i. Ligands that are bound to a target or have unbound
from the substrate are partitioned from those that remain
bound to the substrate. Finally, the partitioned ligands are
amplified via PCR, modeled as a constant factor increase of
αPCR, and used to begin the next cycle. The proceeding
sections highlight the notable details of our hybrid approach,
while a more thorough description and derivation of the model
can be found in the supporting information. Throughout
these sections, quantities that refer to an absolute number
of molecules are denoted with a tilde, while those without
represent concentrations.
Deterministic Model of Ligand Binding. Earlier works use
equilibrium conditions to characterize ligand-target interac-
tions during selection [14–17] , focusing on changes in bulk
properties, such as the mean dissociation constant, to study
the enrichment of a single best candidate. We instead monitor
the full ligand affinity distribution in an effort to better under-
stand how parameters such as the initial standard deviation
also impact selection dynamics. Since modeling each of the
MA ≈ 1015 unique ligands is computationally intractable, we
discretize the initial distribution of MA unique ligands into
MB bins, each containing A˜i ligands of dissociation constant
KD,i, where i = {1, . . . ,MB}. We choose MB to be large
enough that the results do not depend on the binning, and
small enough to optimize simulation performance. We further
build on this analysis by introducing additional equilibrium
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conditions for non-specific ligand-substrate interactions repre-
sented by a dissociation constantKS . In [26], substrate-ligand
binding is accomplished through DNA base pairing using a
fixed sequence, and is thus constant. Altering the length of
this fixed sequence is a means to tune KS . Moreover, different
immobilization techniques, such as the use of graphene ox-
ide [27, 28], will lead to variations of KS within a given pool,
but we do not consider such cases here and consider KS to
be constant throughout a single cycle of SELEX. Combining
ligand-target and ligand-substrate binding, the full system of
steady-state equilibrium binding conditions can be described
by the set of equations:
[SAi] =
1
KS
(AIi − [SAi]− [TAi])Sfree, i = 1, . . . ,MB ,
[TAi] =
1
KD,i
(AIi − [SAi]− [TAi])T free, i = 1, . . . ,MB ,
Stot =
MB∑
i=1
[SAi] + Sfree, T tot =
MB∑
i=1
[TAi] + T free
[1]
Here, [SAi] and [TAi] denote the concentration of ligand-
substrate and ligand-target complexes, representing 2MB in-
dependent variables that are solved; the quantities T tot, T free
and Stot, Sfree denote the concentrations of total and free
target and substrate, respectively. From these results, we
determine the concentration of ligands which survive selection,
denoted by AS,Di , and are amplified by PCR for the next cycle.
The superscripts denote that this number is obtained after
selection and using the deterministic model defined by Eq. (1).
This concentration is simply the sum of free and target-bound
ligands, and is hence given by
AS,Di = [TAi] +A
free
i = A
I
i − [SAi]. [2]
Stochastic Model of Ligand Selection. Chemical reactions are
fundamentally stochastic in nature, with forward and backward
reactions occurring constantly. While powerful and simple,
Eq. (1) is based on real-valued concentrations which require
sufficiently high molecular copy numbers to make discreteness
and random fluctuations negligible. This is challenged at the
tails of the KD distribution, where appropriate binning results
in few ligands per bin. To address this, a hybrid approach
is used where additional stochastic analysis is applied when
Eq. (1) predicts A˜S,Di to be below a threshold Θ. To distinguish
these quantities for stochastic analysis, we denote them as
A˜S,Dψ , where ψ represents the subset of indices i that satisfy
the condition A˜S,Di < Θ. Results exploring the choice for Θ
are provided in SI Fig. S6. We then calculate the probability
for selecting A˜S,Sψ ligands, p
(
A˜S,Sψ
)
; the superscripts denotes
that the number is obtained after selection and using the
stochastic model. As described in the supporting information,
we find that by starting with the chemical master equation,
p
(
A˜S,Sψ
)
is well-approximated by a binomial distribution:
p
(
A˜S,Sψ
)
=
(
A˜totψ
A˜S,Sψ
)
p
A˜
S,S
ψ
ψ (1− pψ)A˜
tot
ψ
−A˜S,S
ψ ,
for A˜S,Sψ = 0, . . . , A˜
tot
ψ
[3]
Here, the quantity pψ represents the probability that a single
ligand is selected out of A˜totψ ligands of type ψ. To provide the
most accurate description, we account for stochastic contribu-
tions from both the immobilization and incubation steps. The
contribution from immobilization is approximately the same for
all candidates, and is given by A˜I
A˜tot
, the fraction of remaining
immobilized ligands after wash steps over those present before
immobilization, where A˜I = ΣMBi=1 A˜Ii and A˜tot = ΣM
B
i=1 A˜
tot
i .
The contribution from incubation is calculated as the fraction
of predicted ligands, A˜S,Dψ , out of an initial number of A˜
I
ψ.
Using these contributions, the total probability that a ligand
in bin ψ survives is given by:
pψ =
A˜IAS,Dψ
A˜totAIψ
[4]
Finally, Eq. (3) requires A˜totψ to be integer-valued, as it denotes
a number of molecules. However, the deterministic equations
yield real-valued concentrations that must be renormalized to
an integer. We separate A˜totψ into its integer and fractional
parts, A˜totψ = A˜totψ,N + A˜totψ,f , and then interpret 0 ≤ A˜totψ,f < 1
as the probability to have an extra molecule present. We then
draw a uniformly distributed random number 0 ≤ r ≤ 1, and
set A˜totψ = A˜totψ,N + 1 if r < A˜totψ,f , and A˜totψ = A˜totψ,N otherwise.
Following this renormalization, we finally draw a random
variate distributed according to Eq. (3) to simulate the set
of ligands A˜S,Sψ that remain after both immobilization and
selection.
Results and Discussion
Utilizing a hybrid computational approach, our model pro-
vides a generalized framework that can be used to analyze
both deterministic and stochastic effects in SELEX. We use
the model to deconstruct two main forms of uncertainties
in aptamer selection. The first is parameter uncertainty, in-
cluding the unknown initial KD distribution as well as the
experimentally tunable quantities KS and T tot. These are
analyzed using a parameter study that observes the impact of
these factors on SELEX dynamics. The second is stochastic
uncertainty associated with low copy number binding phe-
nomena. As this form of uncertainty is random in nature, we
employ Monte Carlo simulations to observe the variability in
outcomes between repeated SELEX procedures and extract
conclusions which are robust with respect to stochastic fluc-
tuations. Unless mentioned otherwise, the parameters from
Table S1 are used in all simulations.
Effect of KD Distribution on Selection Efficiency. Gaussian
distributions describing the initial ligand pool dominate SE-
LEX models in literature [16], yet we are not aware of any
prior systematic approach to study the impact of various distri-
butions on the outcome of SELEX. While strong justifications
have been made for the assumption of a log-normal Gaussian
description [29], we explore various Gaussian as well as non-
Gaussian distributions and their impact on selection. Our
convention for log-normal KD distributions is such that a
Gaussian N(µ, σ) with mean µ and standard deviation σ in
log-space translates to a mean of 10µ in KD space; we do not
shift the mean by 12σ
2 as is customary in Ito calculus. Fig. 2
highlights the dramatic difference observed for just two differ-
ent assumed distributions , and demonstrates the significant
role the initial KD distribution plays in SELEX. This point
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Fig. 2. Initial Distribution affects SELEX dynamics. We plot the distribution of ligand
binding affinities with increasing SELEX cycles for the same experimental parameters
and two different assumed Gaussian distributions at cycle 1, N(−3, 0.4) (blue
triangles) and N(−5, 0.8) (red dots). The dynamics of the two cases are totally
different. ForN(−5, 0.8), the distribution shifts to the left and becomes considerably
narrower, and for N(−3, 0.4), the distribution additionally skews to the left, such
that from cycle 12 on the highest-affinity binders have outcompeted the rest of the
distribution.
Fig. 3. Noise affects SELEX dynamics. We fix the experimental parameters, and
the same initial Gaussian distribution N(−4, 0.4) with the same added noise of only
20 additional ligands initially present between KD = 10−10M and 5× 10−8M .
Two different Monte Carlo simulations show dynamics of selection under random
loss of the 20 strongest binders, (blue triangles), versus dynamics when only two of
those strong binders with affinities between 10−10 and 10−9M are selected, (red
dots). In the latter cases, these two high-affinity binders completely dominate the
distribution from Cycle 12 on and outcompete the remaining ligands with low affinities
(KD > 10−7M ).
is further accentuated by the fact that different selection tar-
gets may significantly alter the initial KD distribution for any
given library. SI Fig. S1 confirms that for a variety of other
distributions, including non-Gaussians, distribution shape has
a dramatic impact on selection dynamics.
In addition to shape, we also explore the assumption that
the KD distribution is continuous everywhere. While this
assumption is credible near the distribution mean where the
frequency of molecules is sufficiently high, we expect it to fail at
the extreme tail where stochastic effects dominate and highly
specific sequences can create gaps in the affinity distribution.
Indeed, it is well-known that even single base-pair changes in
DNA can dramatically impact binding [30]. Ligands in this
regime are highly prized, but may also be at highest risk to
be lost to stochastic effects due to low copy numbers.
We investigate this risk by using an initial N(−4, 0.4) dis-
tribution and adding a fixed noise component that is randomly
sampled from a uniform distribution in log-space. Fig. 3
and Movie S1 show a comparison of two Monte Carlo simu-
lations where there are only 20 ligands present in the range
of KD < 10−7M , i.e. where the continuous Gaussian dis-
tribution is effectively zero. We find that random binding
effects can lead to total loss of those 20 ligands, resulting in a
very different evolution of the KD distribution from cycle 12
onward in comparison to the case where only 2 of those ligands
Fig. 4. Impact of target concentration on SELEX dynamics. Evolution of KD
distribution for three different values of the target concentrations is shown. Under
a high target concentration of T tot = 10−2M , the distribution shifts to the left
and narrows, but does not skew towards high-affinity ligands. Additional skewing is
achieved by reducing to T tot = 10−4M , which increases selection pressure by
intensifying ligand competition. However, further reduction to T tot = 10−8M has
the opposite affect and actually halts selection. In this case, the target concentration
is so low that non-specific ligand-substrate equilibria dominate selection dynamics
and nullifies the selection pressure.
Fig. 5. Optimal target concentrations strongly depend on assumed initial KD
distribution. MeanKD as a measure of pool binding strength for SELEX pool at cycle
20 using different constant target concentration. Depending on the initial distribution
of ligands, we find vastly different optimal target concentrations, i.e. concentrations
with lower mean KD .
survive. SI Fig. S2 shows a distribution of the mean ligand
KD at cycle 20 obtained from 250 Monte Carlo simulations,
confirming this enormous variability in outcomes, where the
mean KD value spans three orders of magnitude.
These results demonstrate the tremendous sensitivity of
selection dynamics to both distribution shape and noise. They
illustrate that selection pressures are parameterized not only by
extrinsic environmental conditions given by the experimental
setup, such as the tunable quantities KS and T tot, but just
as importantly by inherently uncertain intrinsic population
parameters that govern relative competition between ligands
of varying affinities.
Revisiting Target Concentration. Optimization of the target
concentration, T tot, has long stood as a critical step in adjust-
ing selection pressure based on experimental parameters [14–
16]. However, the results from the previous section now suggest
that in addition to these experimental factors, the intrinsic
affinity distribution of the initial ligand pool may have a sig-
nificant influence on the impact T tot exerts on the overall
selection pressure. In light of this, we revisit the topic to study
this impact by varying both T tot and the initial distribution.
Fig. 4 and Movie S2 first show the dramatic impact of
drug concentration on selection dynamics. The results indicate
that T tot = 10−4M (blue) provides optimal selection out of
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Fig. 6. Impact of KS on SELEX dynamics. Evolution of KD distribution for three
different values of KS . Similar to target concentration, we find an optimal outcome
in the middle range (KS = 10−12M , blue), but the outcome for low KS is not
as adverse as for low T tot, since the distribution still shifts towards low KD with
increasing cycles.
Fig. 7. OptimalKS depends on initial distribution. Plot of meanKD for SELEX pool
at cycle 20 using different values of KS . Reducing KS from its optimal value does
not increase the meanKD as strongly as a reduction of the target concentration from
its optimum, as shown in Fig. 5.
the three investigated drug concentrations that use the initial
Gaussian distribution N(−4, 0.4). To investigate the impact
of T tot more systematically, Fig. 5 shows the mean KD value
of ligands selected after 20 cycles as a function of T tot for
nine different initial distributions. Note that as the mean KD
decreases, the average binding strength of the pool increases.
Fig. 5 confirms that intermediate values of T tot yields optimal
selection. SI Figs. S7 (a)-(c) further show that adding noise to
the initial distributions introduces additional variability, but
provides similar qualitative results. Interestingly, we find that
different initial distributions can have very different optimal
T tot, stressing the importance of devising a strategy to miti-
gate this impact and thereby control the inherent uncertainty
associated with the initial KD distribution.
KS Dependence and Non-specific Selection. Our hybrid
model has allowed us to explore the impact of the unknown ini-
tial KD distribution and the target concentration T tot, which
are both present in all SELEX protocols. However, our model
additionally introduces a ligand-substrate interaction that has
never before been studied and offers a unique opportunity to
apply it toward more recent selection schemes aimed at small
molecule aptamer development [26–28]. We therefore extend
our analysis to study uncertainties that govern an optimum
KS , and observe how changes inKS impact selection dynamics
for different KD distributions.
Fig. 6 and Movie S3 show the evolution of a single initial
KD distribution for three different values of KS , showing an
optimal outcome for KS = 10−12M (blue). Noting these dy-
namics, we next vary KS systematically and observe the mean
KD value of ligands present at cycle 20 for nine different initial
KD distributions (Figs. 7, S7(d)-(f)). Similar to target concen-
tration, we find an optimum in the intermediate ranges of KS
and a clear dependence on the initial distribution. However,
contrary to target concentration, the mean KD for smaller
KS is relatively insensitive. Thus, these results suggest that
a lower value of KS = 10−16M would provide similar results
across a multitude of initial distributions.
As it pertains to small molecule selection schemes, these
results provide useful insights into the impact that substrate
binding affinity has on selection efficiency, and may offer some
guidance in the appropriate selection of a substrate material.
The results also provide general insights into the impact of
partitioning efficiency and non-specific binding on selection
across various initial distributions and suggest that a given
partitioning efficiency or fraction of non-specific selection can
impact different initial distributions in vastly different ways.
Improving Selection Efficiency. We have shown that the initial
KD distribution has a tremendous impact on selection effi-
ciency and plays a significant role in modulating the impact of
experimental parameters such as T tot and KS . These results
highlight that while established protocols are expected to per-
form well for some distributions, they may perform moderately
for others. To address this variability in outcomes, we finally
explore strategies to mitigate these impacts using only the
experimental parameters T tot and KS . As a metric for our
analysis, we introduce the quantity φ(c), which describes the
fraction of ligands with KD < 10−10M at cycle c = {1, . . . , C}.
Using this quantity, we further introduce two measures of ef-
ficiency: success probability Φ = φ(C) and success speed SC
defined as the cycle c at which φ(c) = 0.5φ(C).
We have seen that KS and T tot play distinct roles in the
evolutionary dynamics of the KD distribution. However, both
parameters exhibit regimes of optimal selection that depend
heavily on the initial distribution mean and width. Figs. 5
and 7 show that high values for T tot and KS have a similar
impact across all distributions, and suggest a conservative
approach of beginning at these high values for the initial
cycles. This reduces the risk of eliminating high-affinity, low
copy number ligands early on. As these high-affinity ligands are
amplified in subsequent rounds, T tot and KS can be lowered
to rapidly eliminate the remaining low-affinity ligands (see SI
Figs. S3, S4). While ideas to lower the target concentrations
have been discussed previously [26], our results indicate that
other parameters such as KS can be tuned simultaneously to
improve outcome across a multitude of initial distributions and
stochastic conditions. Fig. 8 shows Φ and SC obtained from
50 Monte Carlo simulations of an improved protocol where
both T tot and KS are decreased over the cycles as described in
Table S2. These results are compared to the original protocol
with constant values T tot = 10−4M and KS = 10−12M [26];
SI Fig. S5 shows φ(c) including the standard deviations. Using
six different initial Gaussian distributions with noise added
similar to Fig. 3, we observe that the improved protocol
with decreasing T tot and KS is faster and leads to a higher
fraction of high affinity binders than the original protocol. As
an alternative metric of protocol performance, SI Fig. S8 shows
the evolution of meanKD across the cycles, and also introduces
two alternative protocols where T tot or KS are decreased
faster than in the improved protocol. The results indicate
that while faster decreases can further improve performance
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Fig. 8. Plots comparing the fraction of high-affinity ligands Φ and speed SC of
SELEX for six different KD distributions. The values are obtained from averaging
50 Monte Carlo simulations. We observe that the protocol with decreasing T tot
and KS over the rounds will lead to a higher fraction of strong binders (here, with
KD < 10−10M ), and will reach this fraction faster, than the protocol where T tot
and KS are kept constant.
for some distributions, they may also lead to adverse outcome
for others.
Conclusions and Outlook
Deterministic models for SELEX have shed tremendous insight
on the challenges faced in aptamer selection, but have been un-
able to capture its inherently uncertain nature. Here, we have
presented a hybrid model that captures stochastic binding
and furthermore incorporates non-covalent ligand-substrate
immobilization. Using this framework, we have investigated
previously unexplored questions including the role of the ini-
tial library KD distribution, impact of distribution noise, and
the effect of these factors on the optimization of experimental
parameters such as the total target concentration T tot and
the substrate dissociation constant KS .
The results of our modeling draw striking parallels to out-
comes in evolutionary biology, where environmental parame-
ters define a fitness landscape and competition can change this
landscape to influence survival and reproduction [31]. Within
SELEX, ligands compete for target molecules to ensure sur-
vival into the next cycle, whereas substrate binding traps
the ligands and leads to their removal. Reduction of target
concentration can increase competition, but when few target
molecules are present, even high-affinity binders are unlikely
to find a target. Similar to competition in limited resources
scenarios, we find that the chance of survival for even the
highest affinity ligand strongly depends on the strengths of the
other ligands present in the population. Our surprising find-
ing that a handful of high-affinity ligands can outcompete a
pool of 1015 ligands is also seen in evolutionary biology, where
highly advantageous traits can quickly spread in a population,
given the right conditions. The model enables one to identify
the parameters impacting selection, and can thus be used to
improve selection efficiency. A further important component
of evolution in biological systems is mutations. Mutations in
SELEX can also appear during PCR amplification, but usually
lead to reduced affinities of the strongest aptamers [30], so
we ignored them in our current approach. However, for some
SELEX protocols, mutations can be beneficial to expand the
experimental sampling space [32], and it may be interesting
to extend our model to those protocols.
In summary, our novel model provides a better understand-
ing of the impact of the uncertainties in SELEX, and how
experimental parameters can be tuned to improve outcome
and speed of this expensive and time-consuming protocol. We
have demonstrated how optimization of the parameters can
enhance selection efficiency of one protocol dramatically, and
we envisage that simple adaptations of our model can be used
to improve the many other established protocols, as well as
guide the design of novel protocols, which aim to limit the
impact of uncertainties in selection methods.
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